Biopharma Begins Phase 2 COVID Clinical Trial
Source: Streetwise Reports  (3/10/21)
An update on two of Can-Fite BioPharma's studies involving its lead drug candidate Piclidenoson is provided in a Dawson James report. More >

Materialise Shares Print 27% Higher on Upward Trend in Q4 Revenue
Source: Streetwise Reports  (3/9/21)
Shares of 3D printing firm Materialise NV traded higher after the company reported FY/20 financial results and indicated that sequential quarterly revenue rebounded, increasing by 11.1% in Q4/20. More >

RadNet Shares Rise 17% on Record Q4 Revenue and Bright Outlook for 2021
Source: Streetwise Reports  (3/8/21)
Shares of RadNet Inc. reached a new 52-week high after the diagnostic imaging company reported record revenue and adjusted EBITDA for Q4/21 and offered positive financial guidance for FY/21. More >

Two Studies of Life Sciences Firm's Feed Supplement to Be Featured in Journal
Source: Streetwise Reports  (3/8/21)
The positive results of two studies of Avivagen's OxC-beta in broiler poultry are slated for publication in Poultry Science. More >

Investors Seeing Green as FDA Approves Second Sight Medical's Argus 2s Retinal Prosthesis System
Source: Streetwise Reports  (3/5/21)
Second Sight Medical Products shares trade more than 400% higher after the company reported that the FDA granted approval for its Argus 2s Retinal Prosthesis System designed to deliver useful artificial vision to blind individuals diagnosed with retinitis pigmentosa. More >

Amgen Offers $1.9 Billion to Acquire Five Prime Therapeutics
Source: Streetwise Reports  (3/4/21)
Five Prime Therapeutics shares traded 78% higher after the company reported it entered into a definitive agreement to be acquired by biotech giant Amgen for $38 per share in cash. More >

U.S. Biopharma Making a 'Bold Move into a Large Market Opportunity'
Source: Streetwise Reports  (3/3/21)
This latest undertaking of Dicerna Pharmaceuticals and the near-term catalysts of some of its other programs are described in an H.C. Wainwright & Co. report. More >

Virtual HealthCare Tech Firm Reports Q2 Sequential Revenue Growth of 108%
Source: Streetwise Reports  (3/3/21)
Reliq Health Technologies reported financial results for Q2/21 that demonstrated significant increases in quarterly revenues and gross margins; management expects to achieve profitability in the quarter ending June 30, 2021. More >

FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform
Source: Streetwise Reports  (3/3/21)
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures. More >

Biopharma Chooses Firm to Co-Conduct Psychedelic Dose Trial
Source: Streetwise Reports  (3/2/21)
Algernon Pharmaceuticals aims to begin the study as soon as it receives the drug from the manufacturer. More >

Virtual HealthCare Tech Firm Contracts to Provide Patient Care Platform to US Nephrology Clinic
Source: Streetwise Reports  (2/26/21)
Reliq Health Technologies reported it signed a new agreement with a Texas-based nephrology clinic to provide its iUGO Care platform to patients with chronic kidney disease. More >

Pandion Shares Trade Up 134% on $1.85 Billion Acquisition by Merck
Source: Streetwise Reports  (2/25/21)
Pandion Therapeutics shares reached a new 52-week high after the company reported it agreed to be acquired by pharmaceutical giant Merck & Co. in an all cash transaction for $60 per share. More >

Telehealth Tech Company Continues Rapid Growth in COVID-Changed Landscape
Source: Streetwise Reports  (2/24/21)
Reliq Health introduces iUGO Home services and just added a care management network in California with 50 clinics and over 500 physicians. More >

Analyst: All Systems Are Go for Testing, Testing and More Testing
Source: Streetwise Reports  (2/24/21)
This Dawson James report explains why ProPhase Labs is perfectly positioned to benefit from expanded COVID testing.
More >

U.S. Cannabis Company 'Cashed Up with Catalysts Materializing'
Source: Streetwise Reports  (2/24/21)
The many reasons why Columbia Care is 'due for a catch-up trade' are discussed in an Echelon Capital Markets report. More >

Owens & Minor Shares Soar 36% After Firm Reports Record Q4 Earnings and Positive 2021 Outlook
Source: Streetwise Reports  (2/24/21)
Shares of Owens & Minor Inc. soared to a new 52-week high after the company reported Q4/20 and FY/20 financial results that were boosted by a 58% gain in global products revenue and increases in elective medical procedures. More >

Company's Antibiotic-Free Livestock Feed Product Shows Positive Results in Subclinical Mastitis Dairy Trial
Source: Streetwise Reports  (2/22/21)
Avivagen Inc. reported that data from a New Zealand OxC-betaTâ„¢ Livestock Dairy Trial for use against sub-clinical mastitis has been published in a top-tier international veterinary science journal. More >

Regenerative Medicine Firm Reports Positive Chronic Lower Back Pain Trial Results
Source: Streetwise Reports  (2/17/21)
New study data and next steps for Mesoblast's MPC-06-ID are presented in a Dawson James Securities report. More >

Virtual HealthCare Tech Firm Contracts with California Network of 500+ Doctors and 50 Clinics
Source: Streetwise Reports  (2/17/21)
Reliq Health Technologies reported it signed a new contract with a care management network for its iUGO Care platform to deliver customized healthcare to senior citizens in the Asian-American community throughout California. More >

Digital Therapeutics Leader DarioHealth Makes a Critical Acquisition
Source: Matt Badiali for Streetwise Reports  (2/17/21)
Independent financial analyst Matt Badiali discusses DarioHealth's latest acquisition and what it means for the company's growth. More >

Nektar Therapeutics Planning Phase 2/3 Studies with Merck and SFJ Pharma for Head and Neck Cancer
Source: Streetwise Reports  (2/17/21)
Nektar Therapeutics shares traded 14% higher after the company reported it plans to conduct a Phase 2/3 study of bempegaldesleukin in combination with Merck's KEYTRUDA® in patients with squamous cell carcinoma of the head and neck and is partnering on a second Phase 2/3 study with SFJ Pharmaceuticals that will provide $150 million to fund development. More >

PAVmed Shares Increase 28% after First US Patient Treated with CarpX Device for Carpal Tunnel Syndrome
Source: Streetwise Reports  (2/16/21)
PAVmed Inc. shares reached a new 52-week high after the company reported that the first patient in the U.S. was successfully treated with its CarpX^® Device, a minimally invasive carpal tunnel release surgical instrument. More >

Pharma Developer Contemplates Adding Lung Scarring as Key Endpoint in Phase 2b/3 COVID-19 Trial
Source: Streetwise Reports  (2/12/21)
Algernon Pharmaceuticals reported it is considering adding "lung scarring" as an additional primary endpoint to its Phase 2b/3 COVID-19 Ifenprodil study protocol. More >

ImmunoGen Shares Rise 30% After Firm Reports FY20 Earnings and 2021 Outlook
Source: Streetwise Reports  (2/12/21)
Shares of ImmunoGen Inc. reached a new 52-week high after the company announced Q4/20 and FY/20 business operating and financial results. More >

AC Immune Reports 'Positive Interim Results' from Novel Phase 1b/2a Alzheimer's Vaccine Trial
Source: Streetwise Reports  (2/11/21)
Shares of AC Immune SA traded 15% higher after the firm reported that interim results from the Phase 1b/2a Alzheimer's trial of its ACI-35.030 vaccine demonstrated generation of potent anti-phospho-Tau antibody responses in 100% of older patients with early Alzheimer's disease. More >